New Flu Vaccine (Stem) with or without Booster
Part of Infections clinical trials.
This trial tests a new type of flu vaccine that targets a part of the virus that doesn't change much (the stem). It is given with or without a special booster, and researchers want to see if it provides broader protection against different flu strains.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old and in good general health.
- Have received at least one flu shot between the 2020-2021 and 2024-2025 seasons.
- No flu shot or flu illness in the last 6 months.
- Not have serious health conditions like uncontrolled asthma, diabetes, or a weak immune system.
- Be willing to not get any other flu vaccine during the study and to use birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests whether a flu vaccine with an extra ingredient (called an adjuvant) is safer and works better for older Asian adults with chronic health conditions than a standard flu vaccine. It aims to provide better protection against the flu for people like you.
This trial tests a new quadrivalent influenza (flu) vaccine in adults 18 and older. It aims to see if the vaccine is safe and helps protect against the flu. You may be able to join if you are generally healthy and have not had the flu or a flu shot recently.
Hear when a new Influenza Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.